InsidersTradesSigma
광동제약: directors' dealings · South Korea · DART (FSS)
DART:company-ed168cKR·DART (FSS)Mcap 270.5Bn€Consumer Defensive
Explore the full insider trade history of 광동제약, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Consumer Defensive sector, 광동제약 has recorded 5 insider filings. Market capitalisation: €270.5bn. The latest transaction was reported on 10 March 2026 — Mixed. Among the most active insiders: 이강주. All data is free.
5
Insider Decl.
0
Thresholds
€81,964
3 ops.
Buy Volume
·
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
7380.00 €
Analyst consensus
Income statement
Revenue1659.51 Bn€
Gross profit301.18 Bn€18% margin
Net income20.97 Bn€1.3% margin
Valuation
Beta0.45
Balance sheet & cash
Market cap270.55 Bn€
Total debt303.21 Bn€
Free Cash Flow55.96 Bn€
Debt / Equity43%
Profitability & ownership
ROE3.2%
ROA1.6%
% insiders19.5%
% institutions12.6%
Last declaration on 10 March 2026
Declarations5 total
5 of 5 declarations